Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer
Titel:
Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer
Auteur:
Mavroudis, D. Papakotoulas, P. Ardavanis, A. Syrigos, K. Kakolyris, S. Ziras, N. Kouroussis, C. Malamos, N. Polyzos, A. Christophyllakis, C. Kentepozidis, N. Georgoulias, V.